Pulmonary arterial hypertension Trials in Petah-tikva, Israel
Conditions / Pulmonary arterial hypertension / Petah-tikva, Israel
Clinical trials for Pulmonary arterial hypertension investigate a range of treatment strategies and patient populations.
24 total trials for this combination
Showing top 10 of 24 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03626688 | A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients | COMPLETED | — |
| NCT01112306 | ACT-293987 in Pulmonary Arterial Hypertension | COMPLETED | PHASE3 |
| NCT04576988 | A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR) | COMPLETED | PHASE3 |
| NCT01908699 | Beraprost-314d Added-on to Tyvaso® (BEAT) | COMPLETED | PHASE3 |
| NCT01431326 | Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care | COMPLETED | — |
| NCT02725372 | Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH | TERMINATED | PHASE3 |
| NCT00811018 | A Long-Term, Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial Hypertension | TERMINATED | PHASE3 |
| NCT03683186 | A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension | ENROLLING_BY_INVITATION | PHASE3 |
| NCT05934526 | Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA) | COMPLETED | — |
| NCT01027949 | An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension | COMPLETED | PHASE3 |